How to Keep Working with Cancer

10 ways to make work easier.

Arm yourself with facts.
For example, cancer patients take no more sick time than other workers.

Work with your doctor — to work better.
Talk to your doctor about treatment options, like oral chemotherapy, that can be taken at home. Ask about drugs and other methods for alleviating side effects.

What they don’t know can hurt you.
The Americans with Disabilities Act applies only if your employer knows of your disease.

Study your options.
Know your company’s policies on medical conditions, flex time, telecommuting, etc. before you share your news.

Control the message — or it will control you.
Share your news calmly. People will react accordingly.

People want to help, but don’t know how. Tell them.
Your boss, co-workers, and human resources team can be a source of support. Encourage them.

Present your boss with your game plan.
Be proactive. That way, both of you know the work will get done.

Reasonable requests get reasonable responses.
Work with your employer to make sure everyone’s needs are met.

Know when to say no.
Determine what requires your personal attention. Delegate the rest.

Log on to cancerandcareers.org for more tips, tools and resources.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap